- Report
- September 2024
- 27 Pages
France
From €995EUR$1,079USD£857GBP
- Report
- December 2023
- 25 Pages
Germany
From €825EUR$895USD£710GBP
- Report
- September 2024
- 231 Pages
China
From €3951EUR$4,000USD£3,287GBP
- Report
- February 2024
- 71 Pages
China
From €1778EUR$1,800USD£1,479GBP
- Report
- February 2024
- 100 Pages
China
From €1778EUR$1,800USD£1,479GBP
- Report
- June 2023
- 27 Pages
Global
€12099EUR$12,250USD£10,066GBP
- Report
- March 2023
- 30 Pages
Global
€12099EUR$12,250USD£10,066GBP
- Report
- February 2023
- 27 Pages
Global
€12099EUR$12,250USD£10,066GBP
- Report
- October 2022
- 20 Pages
Global
€12099EUR$12,250USD£10,066GBP
- Training
- 90 Minutes
Global
- Newsletter
- November 2024
- 3 Pages
Europe
From €129EUR$131USD£108GBP
- Drug Pipelines
- January 2022
- 30 Pages
Global
From €346EUR$350USD£288GBP
€494EUR$500USD£411GBP
- Drug Pipelines
- January 2022
- 30 Pages
Global
From €346EUR$350USD£288GBP
€494EUR$500USD£411GBP
- Drug Pipelines
- January 2022
- 30 Pages
Global
From €346EUR$350USD£288GBP
€494EUR$500USD£411GBP
- Report
- February 2024
- 157 Pages
Global
From €3516EUR$3,560USD£2,925GBP
€4395EUR$4,450USD£3,657GBP
- Report
- October 2024
- 88 Pages
Global
From €3500EUR$3,796USD£3,014GBP
- Report
- October 2024
- 101 Pages
Global
From €3500EUR$3,796USD£3,014GBP
- Report
- October 2024
- 73 Pages
Global
From €3500EUR$3,796USD£3,014GBP
- Report
- October 2024
- 98 Pages
Global
From €3500EUR$3,796USD£3,014GBP
- Report
- October 2024
- 74 Pages
Global
From €3500EUR$3,796USD£3,014GBP
The Dermatological Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs used to treat skin conditions. These drugs are used to treat a variety of skin conditions, including acne, eczema, psoriasis, and skin cancer. Dermatological drugs are typically administered topically, although some may be taken orally.
The Dermatological Drugs market is highly competitive, with many companies vying for market share. Major players in the market include Johnson & Johnson, GlaxoSmithKline, Pfizer, Merck, and Novartis. These companies are engaged in research and development of new drugs, as well as marketing and distribution of existing products. Additionally, many smaller companies are involved in the production of generic dermatological drugs. Show Less Read more